Evidence map›Paper›PMID 42615504›Full record

ArticlePain2026

Parabrachial neuropeptide Y Y1 receptor-expressing neurons govern the sensory dimension of neuropathic pain.

Heather N Allen, Tyler S Nelson, Nitsan Goldstein, Naomi K Grabus, Adam Brandner, Faheem Hussain, Nina E Gakii, Albert T M Yeung, Logan V Kirchner, David Hilferty and 3 more

Abstract read
In one paragraph

Article in Pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Heather N AllenDepartment of Anesthesiology and Perioperative Medicine, Center for Neuroscience, Pittsburgh Center for Pain Research, Pittsburgh Project to End Opioid Misuse, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.ORCID 0000-0003-0771-1959
Tyler S NelsonDepartment of Anesthesiology and Perioperative Medicine, Center for Neuroscience, Pittsburgh Center for Pain Research, Pittsburgh Project to End Opioid Misuse, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Nitsan GoldsteinDepartment of Biology, University of Pennsylvania, Philadelphia, PA, United States.
Naomi K GrabusDepartment of Pharmacology and Therapeutics, McKnight Brain Institute, Center for Advanced Pain Therapeutics and Research, University of Florida College of Medicine, Gainesville, FL, United States.
Adam BrandnerDepartment of Anesthesiology and Perioperative Medicine, Center for Neuroscience, Pittsburgh Center for Pain Research, Pittsburgh Project to End Opioid Misuse, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Faheem HussainDepartment of Anesthesiology and Perioperative Medicine, Center for Neuroscience, Pittsburgh Center for Pain Research, Pittsburgh Project to End Opioid Misuse, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Nina E GakiiDepartment of Anesthesiology and Perioperative Medicine, Center for Neuroscience, Pittsburgh Center for Pain Research, Pittsburgh Project to End Opioid Misuse, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Albert T M YeungDepartment of Biology, University of Pennsylvania, Philadelphia, PA, United States.
Logan V KirchnerDepartment of Pharmacology and Therapeutics, McKnight Brain Institute, Center for Advanced Pain Therapeutics and Research, University of Florida College of Medicine, Gainesville, FL, United States.
David HilfertyDepartment of Pharmacology and Therapeutics, McKnight Brain Institute, Center for Advanced Pain Therapeutics and Research, University of Florida College of Medicine, Gainesville, FL, United States.
J Nicholas BetleyDepartment of Biology, University of Pennsylvania, Philadelphia, PA, United States.
Rajesh KhannaDepartment of Pharmacology and Therapeutics, McKnight Brain Institute, Center for Advanced Pain Therapeutics and Research, University of Florida College of Medicine, Gainesville, FL, United States.
Bradley K TaylorDepartment of Anesthesiology and Perioperative Medicine, Center for Neuroscience, Pittsburgh Center for Pain Research, Pittsburgh Project to End Opioid Misuse, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.ORCID 0000-0002-5080-6120

Funding

NEUROPEPTIDERGIC INHIBITION OF SPINAL PAIN TRANSMISSIONR01NS045954 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BRADLEY K. TAYLOR · 2002 to 2026
$7.4M
Training in Mechanisms and Clinical Presentation of PainT32NS073548 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jami Lynn Saloman, BRADLEY K. TAYLOR · 2012 to 2026
$3.1M
Validation of Neuropilin-1 Receptor Signaling in Nociceptive ProcessingRF1NS131165 · NINDS · UNIVERSITY OF FLORIDA · PI KHANNA, RAJESH · 2023 to 2023
$2.0M
Dissecting the Parabrachial Nucleus’s Role in the Development and Maintenance of Neuropathic PainK00NS124190 · NINDS · UNIVERSITY OF FLORIDA · PI Tyler Scott Nelson · 2023 to 2026
$346k
Neuropeptide Y1 Receptor-Expressing Neurons in the Lateral Parabrachial Nucleus in Neuropathic PainF32NS128392 · NINDS · UNIVERSITY OF FLORIDA · PI ALLEN, HEATHER NOEL · 2023 to 2025
$217k
Determining the neural basis of state-dependent dopamine circuit functionF31DK131870 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI GOLDSTEIN, NITSAN · 2021 to 2021
$29k
NIDDK NIH HHS F31 DK131870NINDS NIH HHS 1R01NS14848-01NINDS NIH HHS 5T32NS073548NINDS NIH HHS F32 NS128392NINDS NIH HHS F32NS128392NINDS NIH HHS K00 NS124190NINDS NIH HHS K00NS124190NINDS NIH HHS R01 NS045954NINDS NIH HHS R01NS045954NINDS NIH HHS RF1 NS131165NINDS NIH HHS RF1NS131165NINDS NIH HHS T32 NS073548
6 · The paper itself

Abstract

abstractPain perception involves complex sensory and emotional processes, yet the supraspinal circuits that sustain neuropathic pain remain incompletely understood. Here, we demonstrate that parabrachial nucleus (PBN) neurons expressing the inhibitory G-protein-coupled neuropeptide Y Y1 receptor (Npy1r) are critical modulators of neuropathic pain. Approximately 19% of lateral PBN neurons express Npy1r. Stimulus-evoked Fos activation and calcium dynamics of these neurons increases in mice with spared nerve injury (SNI) compared to sham controls. Pharmacological activation of Y1 receptors or chemogenetic inhibition of Npy1r neurons attenuates SNI-induced mechanical and cold allodynia, without altering baseline sensitivity or conditioned place preference (a measure of affective pain). Preemptive ablation of parabrachial Npy1r neurons before SNI delayed the development of neuropathic hypersensitivity. Conversely, repeated chemogenetic activation of Npy1r neurons produced persistent mechanical and cold hypersensitivity in uninjured animals; this outlasted neuronal activation, indicating sufficiency to drive pain-like states. Viral tracing revealed dense Npy1r projections from lateral parabrachial neurons to forebrain regions including the central amygdala, lateral hypothalamus, zona incerta, and ventromedial thalamus, sites implicated in the sensory and affective dimension of pain. These findings demonstrate that Npy1r-expressing PBN neurons selectively regulate the sensory-discriminative component of neuropathic pain and can maintain long-lasting hypersensitivity even in the absence of injury.

Indexed as

NeuralgiaNeuronsParabrachial NucleusReceptors, Neuropeptide YAnimalsHyperalgesiaMaleMiceMice, Inbred C57BLMice, TransgenicPain Thresholdneuropeptide Y-Y1 receptorNpy1r protein, mouseReceptors, Neuropeptide YNeuropathicNeuropeptide Y Y1 receptorPainParabrachial nucleus

Identifiers

PMID42615504
PMCPMC13528900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.